IBR is a Bruton’s tyrosine kinase (BTK) inhibitor, and BTK is overexpressed on TAMs.The nano-system delivered IBR to the tumor microenvironment efficiently and significantly reduced tumor growth. The gene discussed is BTK; the disease is neoplasm.